138 related articles for article (PubMed ID: 6606393)
1. Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.
Penn RG; Preheim LC; Sanders CC; Giger DK
Antimicrob Agents Chemother; 1983 Oct; 24(4):494-9. PubMed ID: 6606393
[TBL] [Abstract][Full Text] [Related]
2. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Hoepelman AI; Bakker LJ; Verhoef J
Antimicrob Agents Chemother; 1988 Apr; 32(4):473-6. PubMed ID: 3377459
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections.
Horowitz EA; Preheim LC; Safranek TJ; Pugsley MP; Sanders CC; Bittner MJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):299-301. PubMed ID: 3914859
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
Kreis DJ; Augenstein D; Martinez O; Echenique M; Plasencia G; Vopal JJ; Byers P; Gomez GA
Surg Gynecol Obstet; 1986 Jul; 163(1):1-4. PubMed ID: 3726718
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma.
Crots LD; Obeid FN; Horst HM; Bivins BA
Clin Pharm; 1985; 4(3):316-20. PubMed ID: 3891203
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Abbruzzese JL; Rocco LE; Laskin OL; Skubitz KM; McGaughey MD; Lipsky JJ
Am J Med; 1983 Apr; 74(4):694-9. PubMed ID: 6220603
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
Sattler FR; Moyer JE; Schramm M; Lombard JS; Appelbaum PC
Lancet; 1984 Jun; 1(8390):1315-8. PubMed ID: 6145024
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime in treatment of urinary tract infection in patients with spinal cord injury: comparison with moxalactam.
Montgomerie JZ; Gilmore DS; Canawati HN; Morrow JW
Urology; 1990 Jan; 35(1):93-5. PubMed ID: 2404368
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.
Lea AS; Sudan AW; Wood BA; Gentry LO
Antimicrob Agents Chemother; 1982 Jul; 22(1):32-5. PubMed ID: 6214996
[TBL] [Abstract][Full Text] [Related]
11. Tobramycin in the treatment of severe and complicated urinary tract infections.
Bailey RR; Peddie B
N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of moxalactam in complicated urinary tract infections.
Kumazawa J
Rev Infect Dis; 1982; 4 Suppl():S692-5. PubMed ID: 6218585
[TBL] [Abstract][Full Text] [Related]
13. Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section.
Knodel LC; Goldspiel BR; Gibbs RS
Antimicrob Agents Chemother; 1988 Jun; 32(6):853-7. PubMed ID: 3415207
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinical study of tobramycin and gentamicin.
Klastersky J; Hensgens C; Henri A; Daneau D
Antimicrob Agents Chemother; 1974 Feb; 5(2):133-8. PubMed ID: 4599859
[TBL] [Abstract][Full Text] [Related]
15. Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.
Maigaard S; Frimodt-Möller N; Madsen PO
Antimicrob Agents Chemother; 1978 Oct; 14(4):544-8. PubMed ID: 363053
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections.
Madsen PO; Kjaer TB; Mosegaard A
J Infect Dis; 1976 Aug; 134 Suppl():S150-2. PubMed ID: 972274
[TBL] [Abstract][Full Text] [Related]
17. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
Walker BD; Gentry LO
J Infect Dis; 1976 Aug; 134 Suppl():S146-9. PubMed ID: 787449
[TBL] [Abstract][Full Text] [Related]
18. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Carmine AA; Brogden RN; Heel RC; Romankiewicz JA; Speight TM; Avery GS
Drugs; 1983 Oct; 26(4):279-333. PubMed ID: 6354685
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
Yu PK; Edson RS; Washington JA; Hermans PE
Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
Hautmann R; Pranada F; Ahlert G
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
